Molecular Diagnostics Market | Global Analysis Report 2028 North America and Asia Pacific Witnessing Change in Molecular Diagnostics North America dominated the global molecular diagnostics market in 2020, followed by Europe. The region's dominance can be attributed to the increase in diagnostic facilities and emergence of new players in the region. North America is the leading market for molecular diagnostics due to rise in investments by governments in support of molecular diagnostic tests. Surge in incidence of cancer and unhealthy lifestyle leading to severe infectious diseases are fueling growth of the molecular diagnostics market in the region. Other factors such as large geriatric population and rise in demand for personalized medicines are expected to augment the market in North America.



